Dr. Benedict Joseph Maliakkal, MD

Dr. Maliakkal practices at Nashville General Hospital in Nashville, Tennessee, part of Nashville General Hospital.

Dr. Maliakkal's NPI, 1306872155, was assigned on June 23, 2006. Dr. Maliakkal holds Tennessee license 54376.

Dr. Maliakkal's primary practice is Nashville General Hospital, at 1818 Albion Street, Nashville, TN 37208 in Davidson County. The practice phone is (615) 341-4490.

Dr. Maliakkal's primary practice is Nashville General Hospital in Nashville, Tennessee, part of Nashville General Hospital. The medical group on file is Ascension Saint Thomas Medical Partners. Dmand AI also links Dr. Maliakkal to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maliakkal practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Maliakkal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Maliakkal's licenses on file in 2 states: Tennessee and New York.

CMS data shows 61 Medicare services from Dr. Maliakkal across 3 procedure codes in 2024, for 62 Medicare patients. Medicare paid $4,096 for them.

CMS counts 62 Medicare patients who saw Dr. Maliakkal in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 60% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maliakkal's median patient age at 57, with 50% women.

In 2024, Dr. Maliakkal wrote 543 Medicare Part D claims for 68 patients. 76% of them were for generic drugs. CMS names the drug for 259 of them, across 12 drugs with 11 or more claims each, at $171,138 in total drug cost. In 2023, CMS named 214 claims across 12 drugs.

Dr. Maliakkal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of colonoscopy by Dr. Maliakkal, more than 43% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 59 papers to Dr. Maliakkal, published from 2011 to 2024. 2019 was the busiest year, with 10. The most frequent topics are Liver Cirrhosis, Antiviral Agents and Liver Transplantation. Dr. Maliakkal has published most often in Cureus. Dr. Maliakkal's most frequent co-authors are Paul J. Thuluvath, MD, Patrick S. Kamath, MD and Satheesh Padmanabhan Nair, MD.

Dmand AI links Dr. Maliakkal to 3 clinical trials. Conditions studied include Carcinoma, Hepatocellular, Liver Cirrhosis, Biliary and Non-alcoholic Fatty Liver Disease.

CMS Open Payments shows 126 general payments to Dr. Maliakkal from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Abbvie Inc. paid the most, $17,999.